China’s digital medicine innovation brand

Innovate digital operations, digital services, and digital customer acquisition, empower the industrial chain, and use digital medicine to protect life and health.

SEE MORE +

"One body, two wings and three pillars" development strategy

Integration: Focus on the field of chronic diseases and expand other characteristic market segments; Two wings: integration of raw materials and preparations, integration of excipients and preparations; Three pillars: technology research and development, intelligent manufacturing, and cultural marketing.

SEE MORE +

Healthy China Commitment with Heart

Gather the strength of progress and make a commitment to our country and country; gather the strength of science and technology and pledge to health; gather the strength of humanity and pledge to the future.

SEE MORE +
scroll down

PRODUCT SERIES

A modern, high-tech and innovative pharmaceutical enterprise integrating R & D, production and sales of chemicals, covering the central nervous system, cardio-cerebrovascular and hypoglycemic drugs.

CORE PRODUCT

A modern, high-tech and innovative pharmaceutical enterprise integrating R & D, production and sales of chemicals, covering the central nervous system, cardio-cerebrovascular and hypoglycemic drugs.

Yimeian

[Trade Name] Yimeian [Common Name] Fluoxetine Hydrochloride Dispersible Tablets [Ingredients] The active ingredient of this product is Fluoxetine Hydrochloride. [Character] This product is white or off-white oval tablet. [Indications] Depression; obsessive-compulsive disorder; bulimia nervosa: as an adjunct to psychotherapy to reduce bulimia and catharsis.

View details +

Forrest

[Trade Name] Forrest [Common Name] Amlexanox Paste [Ingredients] The main ingredient of this product is Amlexanox. [Character] This product is a white or off-white thick semi-solid containing a large amount of solid powder. [Indications] It is suitable for the treatment of aphthous oral ulcers (recurrent oral ulcers) with a normal immune system.

View details +

Xinshu

[Trade name] Xinshu [Common Name] Isosorbide Dinitrate Spray [Ingredients] The main ingredient of this product is Isosorbide Dinitrate. [Character] The content of this product is colorless or almost colorless clear liquid. [Indications] It is used for the prevention and treatment of various coronary heart diseases and angina pectoris, especially for moderate and severe angina pectoris attacks. When there are factors that induce angina pectoris such as mental stress and overwork, or there are aura symptoms, using this product in advance can prevent the attack of angina pectoris.

View details +

Xinkechun

[Trade Name] Xinkechun [Common Name] Isosorbide Mononitrate Extended Release Tablets [Ingredients] The main ingredient of this product is Isosorbide Mononitrate. [Character] This product is a film-coated tablet, which is white or off-white after removing the coating. 【Indications】 1. Long-term treatment of coronary heart disease. 2. Long-term treatment and prevention of angina pectoris (including after myocardial infarction). 3. Combined with digitalis and/or diuretics to treat chronic congestive heart failure.

View details +

ABOUT US

A modern, high-tech and innovative pharmaceutical enterprise integrating R & D, production and sales of chemicals, covering the central nervous system, cardio-cerebrovascular and hypoglycemic drugs.

The company's registered capital is 170 million yuan, and the factory covers an area of 55,000 square meters. The company has production lines for tablets, capsules, pastes and sprays. The annual output of tablets and capsules can reach 1.1 billion pieces/grain, and pastes and sprays can reach 5 million bottles. The company currently has 40 drug production approval documents, of which 29 drugs are included in the national medical insurance list, and 18 drugs are included in the national essential drug list. The main product, fluoxetine hydrochloride dispersible tablets, is the only dispersible tablet in the country

2002 Year

The company was founded in 2002

170 million yuan

Registered capital of 170 million yuan

Company Culture

Learn more

Quality Control

Learn more

Partner

Learn more
Explore more content →

News

A modern, high-tech and innovative pharmaceutical enterprise integrating R & D, production and sales of chemicals, covering the central nervous system, cardio-cerebrovascular and hypoglycemic drugs.